期刊文献+

内皮素-1对肝硬化大鼠不同病期离体肝脏及血管环调节作用的研究 被引量:7

Effects of ET-1 on isolated perfused rat liver and vascular rings at two stages of cirrhosis
原文传递
导出
摘要 目的 探讨不同浓度内皮素 1(ET 1)对早、晚期肝硬化大鼠离体肝脏及血管环调节作用及其变化规律。方法 皮下注射CCl4制备大鼠肝硬化模型 ,在造模 9周末和 14周末采用离体肝灌注和离体血管环技术研究不同浓度ET 1对早、晚期肝硬化大鼠肝血流动力学及血管环的调节作用。结果 晚期组 (n =8)肝硬化大鼠基础状态门静脉压 (Ppv) (2 36± 0 2 9)高于早期组 [1 5 4± 0 2 1,(n =8) ],均高于正常对照组 [1 18± 0 13,(n =8) ],各组间Phv差异无显著意义。给予ET 1后 ,门静脉灌注压 (PVP)随ET 1浓度增加而升高 ,晚期组较早期组升高更为明显 ,均高于正常对照组 ,而离体血管环对不同浓度ET 1的浓度累积反应曲线随病期进展而右移 ,同一病期血管环随ET 1浓度增加而收缩性增强 ,但均低于正常对照组 ,0 1nmol/LET 1对晚期组有轻度扩血管作用。结论 ET 1可明显增加肝循环阻力 ,在肝硬化大鼠此种阻力增加作用强于正常大鼠 ,且随肝硬化程度加重而增强 ,而外周血管对ET 1的反应性随病期进展而下降 ,表明ET 1在门脉高压的形成和维持中发挥重要作用。 Objective To investigate the effects of ET 1 on isolated perfused rat liver and vascular rings at early and late stages of cirrhosis Methods Liver cirrhosis was induced by an intraperitoneal injection of 50% CCl 4(0 3 ml/100g, twice a week) In the 9 th and 14 th weekend after injecting CCl 4, the isolated perfused liver and vascular rings were performed to evaluate effects of four concentrations of ET 1 on early and late stages of cirrhosis Results The Ppv of L HC group at baseline was higher than that of E HC group, both were higher than that of the controls However, there showed no differences on Phv in these groups With the concentration of ET 1 increasing, PVP was elevated accordingly in E HC and L HC group L HC group showed higher PVP compared with E HC group, both were higher than the controls While in isolated vascular rings, with the deteriorating of cirrhosis, the cumulative response curves showed right shift 0 1 nmol/L ET 1 showed mild relaxation on vascular rings in L HC group Conclusion ET 1 can increase the PVP, especially with the deterioration of cirrhosis, there showed higher reaction compared with normal controls The vascular rings showed low response on the contrary So ET 1 plays an important role in the pathogenesis of portal hypertension In view of its different roles on liver and vascular rings at early and late stages, administration of different selective antagonist of ET receptor at different stages of cirrhosis should be well considered
出处 《中华医学杂志》 CAS CSCD 北大核心 2002年第22期1565-1568,共4页 National Medical Journal of China
关键词 离体肝脏 血管环 内皮素-1 肝硬化 门脉高压 发病机制 endothelin 1 liver cirrhosis perfusion vascular rats
  • 相关文献

参考文献15

  • 1Pinzani M, Milani S, De Franco R, et al. Endothelin-1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology, 1996, 110:534-548.
  • 2Shah V. Portal hypertension and the hyperdynamic circulation: nitric oxide in a haze of cannabinoid smoke. Hepatology, 2001, 34:1060-1061.
  • 3Rockey D. The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin and nitric oxide. Hepatology, 1997,25:2-5.
  • 4Helmy A, Jalan R, Newby DE, et al. Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well- compensated cirrhosis. Hepatology, 2001,33: 826-831.
  • 5Yu Q, Shao R, Qian HS ,et al. Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension. J Clin Invest,2000,105: 741-748.
  • 6Kamath PS, Tyce GM, Miller VM, et al. Endothelin-1 modulates intra- hepatic resistance in a rat model of noncirrhotic portal hypertension. Hepatology, 1999,30:401-407.
  • 7Wang HG, Shibamoto T, Miyahara T. Endothelin-1 selectively contracts portal vein through both ETA and ETB receptors in isolated rabbit liver. Am J Physiol, 1997,273:G1036-G1043.
  • 8Zhang B, Calmus Y, Wen L,et al.Endothelin-1 induced liver vasoconstriction through both ETA and ETB receptors. J Heptol, 1997,26:1104-1110.
  • 9Blendis L, Wong F. The hyperdynamic circulation in cirrhosis: an overview. Pharmacol Ther,2001,89:221-231.
  • 10Ivy D, McMurtry IF, Yanagisawa M, et al. Endothelin B receptor deficiency potentiates ET-1 and hypoxic pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol, 2001,280:L1040-1048.

同被引文献37

  • 1DENG,Xiaorong,(邓小荣),YANG,Zhen,(杨镇).Increased Expression of Endothelin Receptors in Human Cirrhosis—— Relationship with Splanchnic Hemodynamics[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2002,22(1):37-41. 被引量:1
  • 2杨利剑.不同生长抑素制剂治疗食管静脉曲张出血31例[J].世界华人消化杂志,2000,8(z1). 被引量:5
  • 3Feng Liu1,Ji Xin Li2, Chun Mei Li2,Xi Sheng Leng2 1Department of General Surgery, the Fifth Affiliated Hospital, Harbin Medical University, Harbin 150036, Heilongjiang Province, China2Department of General Surgery, People’s Hospital, Medical University, Beijing 100044, China.Plasma endothelin in patients with endotoxemia and dynamic comparison between vasoconstrictor and vasodilator in cirrhotic patients[J].World Journal of Gastroenterology,2001,7(1):126-127. 被引量:8
  • 4杨文燕,吴建新,戴强,江佛湖,赵力民,张燕捷,朱黎明,王碧君.长效奥曲肽影响大鼠肝纤维化形成的研究[J].中国医药导报,2007,4(09Z):17-19. 被引量:2
  • 5Nanji AA, Jokelainen K, Tipoe GL, Rahemtulla A, Dannenberg AJ. Dietary saturated fatty acids reverse inflammatory and fibrotic changes in rat liver despite continued ethanol administration. J Pharmacol Exp Ther 2001; 299:638-644.
  • 6Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol 1999; 20:157-198.
  • 7Fort J, Oberti F, Pilette C, Veal N, Gallois Y, Douay O, Rousselet MC, Rosenbaum J, Cales P. Antifibrotic and hemodynamic effects of the early and chronic administration of octreotide in two models of liver fibrosis in rats. Hepatology 1998; 28:1525-1531.
  • 8Sharma K, Patel YC, Srikant CB. C-terminal region of human somatostatin receptor 5 is required for induction of Rb and G1 cell cycle arrest. Mol Endocrinol 1999; 13:82-90.
  • 9Chowers Y, Cahalon L, Lahav M, Schor H, Tal R, Bar-Meir S, Levite M. Somatostatin through its specific receptor inhibits spontaneous and TNF- alpha- and bacteria-induced IL-8 and IL-1 beta secretion from intestinal epithelial cells. J Immunol 2000; 165:2955-2961.
  • 10Pinzani M, Milani S, De Franco R, Grappone C, Caligiuri A, Gentilini A, Tosti-Guerra C, Maggi M, Failli P, Ruocco C, Gentilini P. Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. Gastroenterology 1996; 110:534-548.

引证文献7

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部